CF Industries Holdings
CF INDUSTRIES HOLDINGS, INC.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$7.1B
Operating marginCalculated
32.5%
Net assets to total assetsCalculated
34.3%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★★position among all companies
32.5%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.0%
Capital efficiency
Could not be retrieved
Revenue and profit
Performance, financial position and capital allocation
CF Industries Holdings
Recent performance trends
CF Industries Holdings
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$6.5 billion | US$11.2 billion | US$6.6 billion | US$5.9 billion | US$7.1 billion |
| Operating income | US$1.7 billion | US$5.4 billion | US$2.2 billion | US$1.7 billion | US$2.3 billion |
| Total assets | US$12.4 billion | US$13.3 billion | US$14.4 billion | US$13.5 billion | US$14.1 billion |
| Shareholders' equity | US$3.2 billion | US$5.1 billion | US$5.7 billion | US$5.0 billion | US$4.8 billion |
| Net cash provided by (used in) operating activities | US$2.9 billion | US$3.9 billion | US$2.8 billion | US$2.3 billion | US$2.8 billion |
| Net cash provided by (used in) investing activities | US$-0.5 billion | US$-0.4 billion | US$-1.7 billion | US$-0.5 billion | US$-0.9 billion |
| Net cash provided by (used in) financing activities | US$-1.5 billion | US$-2.7 billion | US$-1.4 billion | US$-2.2 billion | US$-1.5 billion |
| Cash and cash equivalents | US$1.6 billion | US$2.3 billion | US$2.0 billion | US$1.6 billion | US$2.0 billion |
Revenue scale in the same industry
CF Industries Holdings
Chemicals and pharmaceuticals: 56 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Johnson & JohnsonFY Dec 2025 US$94.2B
- 2 Procter & GambleFY Jun 2026 US$87.0B
- 3 ELI Lilly ANDFY Dec 2025 US$65.2B
- … 26 companies
- 30 RPM InternationalFY May 2026 US$7.9B
- 31 The CloroxFY Jun 2025 US$7.1B
- 32 CF Industries HoldingsThis companyFY Dec 2025 US$7.1B
- 33 Dupont DE NemoursFY Dec 2025 US$6.8B
- 34 OlinFY Dec 2025 US$6.8B
- … 22 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.9 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$2.0 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-1.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.9 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$2.8 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.9 billion | Consolidated | Disclosed |
| Dividends paid | US$0.3 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$7.8 billion | Consolidated | Disclosed |
| Non-controlling interests | US$2.9 billion | Consolidated | Disclosed |
| Net assets | US$4.8 billion | Consolidated | Disclosed |
| Net sales | US$7.1 billion | Consolidated | Disclosed |
| Operating income | US$2.3 billion | Consolidated | Disclosed |
| Total assets | US$14.1 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$1.4 billion | Consolidated | Disclosed |
| Operating margin | 32.5% | Consolidated | Calculated |
| Net assets to total assets | 34.3% | Consolidated | Calculated |
| Net margin | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |
| Return on equity | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |